Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Intra-Cellular Therapies Inc. buy Morgan Stanley

Intra-Cellular Therapies Inc.
Start price
€69.00
11.10.24 / 50%
Target price
€86.77
11.10.25
Performance (%)
78.26%
End price
-
12.10.25
Summary
This prediction is currently being closed. With a performance of 78.26% the BUY prediction by Morgan_Stanley is a big success. Morgan_Stanley has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Intra-Cellular Therapies Inc. - - -
iShares Core DAX® 4.244% 2.864% 14.030%
iShares Nasdaq 100 4.890% 2.814% 32.707%
iShares Nikkei 225® 9.397% 7.826% 48.296%
iShares S&P 500 3.528% 1.950% 25.247%

Comments by Morgan_Stanley for this prediction

In the thread Intra-Cellular Therapies Inc. diskutieren
Prediction Buy
Perf. (%) 78.26%
Target price 86.773
Change
Ends at 11.10.25

Intra-Cellular Therapies, Inc. (NASDAQ: ITCI) had its price target raised by analysts at Morgan Stanley from $92.00 to $95.00. They now have an "overweight" rating on the stock.
Ratings data for ITCI provided by MarketBeat

Morgan Stanley 
0
Report Share
11.10.24
In the thread Trading Intra-Cellular Therapies Inc.
Prediction Buy
Perf. (%) 78.26%
Target price 86.773
Change
Ends at 11.10.25

Die von Morgan_Stanley gewählte maximale Laufzeit wurde überschritten

Morgan Stanley 
0
Report Share
12.10.25

Stopped prediction by Morgan_Stanley for Intra-Cellular Therapies Inc.

buy
Intra-Cellular Therapies Inc.

Start price
Target price
Perf. (%)
€53.20
04.08.23
€72.52
04.08.24
28.76%
05.08.24

Morgan Stanley 
04.08.23 50%